Cabaron, Letecia P.

HRN: 22-08-78  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/07/2026
CEFTRIAXONE 1G (VIAL)
05/07/2026
05/13/2026
IV
2g
OD
CAP HR
Checking Initial Appropriateness 
05/07/2026
AZITHROMYCIN 500MG IV
05/07/2026
05/11/2026
IV
500mg
OR
CAP HR
Checking Initial Appropriateness 
05/11/2026
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
05/11/2026
05/11/2026
IV
4.5g
Ld
Caphr
Checking Initial Appropriateness 
05/11/2026
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
05/11/2026
05/18/2026
IV
2.25g
Q6h
CAP-HR
Checking Initial Appropriateness 
05/15/2026
LEVOFLOXACIN 5MG/ML, 100ML (VIAL)
05/15/2026
05/15/2026
IV
500mg
LD
Capmr Cuti
Checking Initial Appropriateness 
05/15/2026
LEVOFLOXACIN 5MG/ML, 100ML (VIAL)
05/15/2026
05/22/2026
IV
250
Od
Capmr Cuti
Checking Initial Appropriateness 
05/18/2026
SILVER SULFADIAZINE 1%, 25G CREAM (TUBE)
05/18/2026
05/24/2026
TOPICAL
1%
BID
Decubitus Ulcer
Checking Initial Appropriateness 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: